MedTrace Logo

An Interactive Advance Care Planning Intervention to Facilitate a Good Death for Cancer Patients

NCT01912846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 466

Last updated 2019-04-02

No results posted yet for this study

Summary

The purpose of this 5-year interventional study is to design, implement, and evaluate the effectiveness of an intervention aimed at facilitating prognosis communication and end-of-life care decision-making to increase the extent of congruence between the patient's preferred and actual EOL care received and patients' and family caregivers' QOL and psychological well-being, reduce futile aggressive healthcare resources utilization at end-of-life, and facilitate bereavement adjustment.

Conditions

  • End Stage Cancer

Interventions

BEHAVIORAL

Interactive advance care planning

The facilitator will begin each course of intervention by assessing the patient's and his/her family caregiver's readiness for engagement in ACP independently. Providing participant-centered care tailored to the specific needs of participants at each stage of readiness for engagement in ACP. Facilitating EOL care discussions throughout the dying process. A workbook and a video decision aid that briefly describes ACP to enhance participants' understanding of the essential elements in ACP.

BEHAVIORAL

Attention usual care

a consistent master prepared nurse on the study team will provide the attention portion of the care. The initial meeting will occur before the patient discharges from hospital and the usual care nurse will give patients and family caregivers a workbook and a video with educational materials on how to manage common symptoms and a comprehensive list of resources available, including patient support organizations, support and financial assistance through the social work department..

Sponsors & Collaborators

  • Chang Gung University

    lead OTHER

Principal Investigators

  • Siew Tzuh Tang, DNSc · School of Nursing, Chang Gung University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01912846 on ClinicalTrials.gov